Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani Announced that Seven Factories had been Referred to the Public Prosecutor for Using the Banned Rhodamine B

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani held a press conference during which he announced the findings of the samples of pickled turnips taken by health inspectors from all the factories across Lebanon.

Hasbani stated that the ministry had conducted inspections on 34 institutions that produce pickles. The following was found:
  • 59% of these factories had a license to operate from the Ministry of Industry
  • 73% of the factories totally abide by the health conditions
  • Only 50% of these factories used proper containers to store food while 50% used partially or totally containers that are not proper for storage.
Health Minister reminded that the Ministry of Public Health had conducted inspections on pickles factories at the beginning of 2017 and issued warnings to the users of unhealthy containers.
 
Rhodamine B, the internationally banned dye for potentially causing cancer, is not a registered substance that the Ministry of Public health allows to enter to Lebanon as a food supplement (according to law No.912/1 issued on 5 may 2014.)

This substance is also banned by decision issued by the Minister of Industry (No. 119/1 of 15 September 2017.)

Hasbani added that the findings show the following:
  • 25% of the samples taken from 28 factories that produce turnips contain Rhodamine B
  • 68% of the samples contain dyes other than Rhodamine B, which are also banned by decision No. 119/1 issued by the Minister of Industry 
Therefore, the Ministry of Public health referred 7 factories to the public prosecutor and reports were sent to the Ministries of Economy, Agriculture and Economy on the inspections and findings.
    2
ATC Name B/G Ingredients Dosage Form Price
N01AH06 ULTIVA B Remifentanil (HCl) - 5mg 5mg Injectable powder for solution 2,990,050 L.L
C10AA07 UBSATOR-CA G Rosuvastatin (calcium) - 10mg 10mg Tablet, film coated 499,142 L.L
C10AA07 UBSATOR-CA G Rosuvastatin (calcium) - 20mg 20mg Tablet, film coated 499,142 L.L
A07FA02 ULTRA LEVURE B Saccharomyces boulardii - 100mg 100mg Powder for suspension 536,193 L.L
A07FA02 ULTRA LEVURE B Saccharomyces boulardii - 200mg 200mg Capsule 513,348 L.L
A07FA02 ULTRA LEVURE B Saccharomyces boulardii - 50mg 50mg Capsule 381,651 L.L
B01AC27 UPTRAVI B Selexipag - 1000mcg 1000mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 1200mcg 1200mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 1400mcg 1400mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 1600mcg 1600mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 200mcg 200mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 200mcg 200mcg Tablet, film coated 613,462,617 L.L
B01AC27 UPTRAVI B Selexipag - 400mcg 400mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 600mcg 600mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 800mcg 800mcg Tablet, film coated 275,097,581 L.L
G04BD08 URICARE G Solifenacin succinate - 10mg 10mg Tablet, film coated 1,334,884 L.L
G04BD08 URISOL G Solifenacin succinate - 10mg 10mg Tablet, film coated 1,334,884 L.L
G04BD08 URICARE G Solifenacin succinate - 5mg 5mg Tablet, film coated 1,334,884 L.L
G04BD08 URISOL G Solifenacin succinate - 5mg 5mg Tablet, film coated 1,334,884 L.L
A05AA02 URSOFALK B Ursodeoxycholic acid - 250mg 250mg Capsule 2,823,413 L.L
    2
Sitemap
© Copyrights reserved to Ministry of Public Health 2025